Savara to present at oppenheimer's 32nd annual healthcare conference

Austin, texas--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at oppenheimer's 32nd annual healthcare conference on march 16, 2022 at 3:20 pm et. a live webcast of the presentation will be available on savara's website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days. about savara savara is a clinical stage biopharmaceutical
SVRA Ratings Summary
SVRA Quant Ranking